| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2072087 | Advanced Drug Delivery Reviews | 2005 | 6 Pages |
Abstract
It is likely that micro- and nano-particulates will become an important component of targeted clinical pharmacotherapeutics in patients with neovascular AMD.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Andrew A. Moshfeghi, Gholam A. Peyman,